Ticker: MET

MetLife

Finance Financials Insurance - Life

Price 99.98

Reco Buy Potential 70 Risk 40 Updated 2026-10-27

Official website

Forecast impact

neutral

Target +9.0% target fill 91.7%

Reaction D5 -2.98% · D10 -5.50%

Impact Potential 0 · Risk 0 valid until 2026-11-06

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell

Description

Company and Business Model

MetLife, Inc. is a leading global provider of insurance, annuities, and employee benefit programs. The company operates through various segments, including U.S. Retail, Group Benefits, and International. Its core products encompass life insurance, health insurance, and retirement solutions. Major revenue sources include premiums from insurance policies, investment income, and fees from asset management services.

Investment Profile

The investment profile of MetLife suggests it may appeal to value investors due to its stable dividend yield and established market position. The company has a history of consistent earnings, although recent revenue fluctuations may warrant caution. Overall, it presents a balanced opportunity for investors seeking income and potential capital appreciation.

Category: Finance Sector: Financials Industry: Insurance - Life Investment style: Growth Horizon: Long-term Company type: Blue Chip Company type: Large Cap

Fundamental metrics (experimental) Updated: 2026-10-27

EPS (TTM) — earnings per share for the last 12 months, $: 5.25
Revenue QoQ — quarter-over-quarter revenue growth: -1.0%
EPS surprise: 5.7%
20d volatility: 1.6%
Dividend yield: 2.9%
last ex-date: 2026-11-03

AI recommendation changes

Date	Before	After	Reason
2026-10-27	Hold	Buy	Solid fundamentals, but mixed momentum signals present uncertainty.
2026-10-25	Buy	Hold	Weak momentum and high risk offset potential upside.
2026-10-23	Hold	Buy	Strong momentum and solid fundamentals support growth potential.
2026-10-15	Buy	Hold	Solid fundamentals, but mixed momentum signals present uncertainty.
2026-10-07	Hold	Buy	Solid fundamentals, but mixed momentum signals.
2026-09-30	Buy	Hold	Mixed performance; cautious outlook amid market pressures.
2026-08-16	Hold	Buy	Solid fundamentals, but mixed momentum signals present uncertainty.
2026-08-08	Buy	Hold	Weak revenue growth raises concerns despite positive EPS surprise.
2026-07-28	Hold	Buy	Strong momentum and solid dividend yield support growth.
2026-07-09	Buy	Hold	Weak revenue growth raises concerns despite solid EPS surprise.
2026-07-03	Hold	Buy	Strong momentum but revenue decline raises concerns.
2026-07-01	Buy	Hold	Weak revenue growth raises concerns despite solid EPS.
2026-06-27	Hold	Buy	Solid fundamentals, but mixed momentum signals present risks.
2026-06-25	Buy	Hold	Weak revenue growth and negative short-term momentum.
2026-06-23	Hold	Buy	Mixed signals; strong momentum but revenue decline concerns.
2026-06-19	Buy	Hold	Weak revenue growth raises concerns despite solid EPS.
2026-06-09	Hold	Buy	Mixed performance; cautious due to revenue decline.
2026-06-01	Buy	Hold	Mixed performance; cautious outlook amid revenue decline.
2026-05-16	Hold	Buy	Stable dividend, but revenue decline raises concerns.
2026-05-08	—	Hold	Weak revenue growth raises concerns; hold for dividends.
2026-05-08	Buy	Buy	Компания MetLife демонстрирует умеренный рост за последние 20 дней, однако недавние падения и снижение выручки указывают на определенные риски. Уровень дивидендной доходности также привлекательный, что делает акцию интер
2026-04-09	Hold	Buy	Компания демонстрирует сильный рост выручки и положительную динамику цен на акции в краткосрочной перспективе. Дивидендная доходность также привлекательна, что делает акцию интересной для инвесторов.
2026-02-24	Buy	Hold	Компания демонстрирует стабильные финансовые показатели, однако недавнее снижение цены акций и высокая волатильность вызывают опасения. Рекомендуется удерживать акции до прояснения ситуации на рынке.
2026-02-14	Hold	Buy	Компания показывает стабильные финансовые результаты с хорошим ростом выручки, однако недавнее снижение цены акций и негативная динамика за 120 дней указывают на возможные риски.

Analyst forecasts

Date	Analyst	Action	Target	Price Then
2026-10-07	Mizuho Securities	Target Lowered	112 → 109	97.16
2026-10-07	Barclays	Target Raised	97 → 111	97.16
2026-10-06	UBS	Target Raised	105 → 110	96.88
2026-09-22	Piper Sandler	Update	— → 110	96.64
2026-08-24	Morgan Stanley	Target Raised	103 → 111	95.75
2026-08-19	Wells Fargo	Target Raised	101 → 109	96.73
2026-08-06	Barclays	Target Raised	94 → 97	96.26
2026-07-15	Atlantic Equities	Target Lowered	106 → 103	92.44
2026-07-10	Jefferies	Target Raised	97 → 103	91.15
2026-07-08	UBS	Target Raised	102 → 105	90.27
2026-07-07	Barclays	Target Raised	93 → 94	90.46
2026-07-06	Morgan Stanley	Target Raised	93 → 103	90.93
2026-06-24	Piper Sandler	Target Raised	86 → 90	88.03
2026-05-26	Piper Sandler	Target Raised	81 → 86	84.06
2026-05-21	Morgan Stanley	Target Raised	89 → 93	83.5
2026-05-12	Wells Fargo	Target Raised	90 → 95	77.98
2026-05-08	Mizuho Securities	Target Raised	93 → 95	78.82
2026-05-07	Barclays	Target Raised	89 → 93	80.16
2026-04-13	Mizuho Securities	Target Lowered	100 → 93	74.63
2026-04-09	Evercore ISI	Target Raised	95 → 96	74.65
2026-04-09	UBS	Target Raised	98 → 102	74.65
2026-02-12	Mizuho Securities	Target Lowered	102 → 100	78.89
2026-02-10	Evercore ISI	Target Lowered	— → 95	77.92

News Page 1 of 1

Investors Shift Focus from AI Stocks as Non-Tech Sectors Gain Momentum

10/26/2026, 10:39 AM investing review finance Viking Holdings MetLife Republic Services Eli Lilly

Investors are increasingly favoring non-AI stocks as a rotation occurs away from technology, with a Goldman Sachs index tracking the S&P 500 without AI enablers showing strong performance relative to the traditional index. This shift highlights the potential for diversification and stability in sectors less affected by recent tech selloffs.

Apple (AAPL) Hits New High as Market Anticipates Earnings Reports from American Express (AXP) and Western Digital (WDC)

10/22/2026, 04:37 PM investing review Western Digital Nvidia MetLife Marsh McLennan American Express Apple

The Nasdaq Composite experienced its worst day since June, while Apple reached a new stock high, closing at $348.22, and is on track to potentially surpass Nvidia in market capitalization. Investors are also closely watching earnings reports from American Express and developments in the cybersecurity sector.

MetLife (MET) Positioned for Growth Amid Strong Demand and AI Efficiency

06/29/2026, 09:38 AM investing growth finance MetLife

MetLife is demonstrating strong growth in the life insurance sector, with significant increases in premiums and a favorable outlook for earnings, making it an attractive investment opportunity.